EXPRESS SCRIPTS HOLDING COMPANY (NASDAQ:ESRX) Files An 8-K Regulation FD Disclosure

ME Staff 8-k
-
0

EXPRESS SCRIPTS HOLDING COMPANY (NASDAQ:ESRX) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

• unexpected costs regarding the proposed merger;
• diversion of management’s attention from ongoing business operations and opportunities;
• potential litigation associated with the proposed merger;
• the ability to retain key personnel;
• the availability of financing;
• effects on the businesses as a result of uncertainty surrounding the proposed merger; and
• the industry may be subject to future risks that are described in SEC reports filed by Express Scripts Holding Company and Cigna Corporation.


Express Scripts Holding Co. Exhibit
EX-99.1 2 d495652dex991.htm EX-99.1 EX-99.1 Express Scripts KEY FACTS FOR CIGNA INVESTORS Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication,…
To view the full exhibit click here